Literature DB >> 20963448

Generalized allergy due to zinc in insulin treated with zinc-free insulin.

Ines Ben Ammar1, Habib Ksouri, Nabil Trabelsi, Fethi Mellouli, Faïka Ben Mami, Saber Dakhli, Ahmed Achour.   

Abstract

Allergy to insulin became a rare complication due to the introduction of recombinant human insulin preparations. Nevertheless, allergic reactions to components of such preparations can occur. We report a case of a 61-year-old man with an atopic background and affected by diabetes mellitus type 2 since 27 years, who experienced generalized allergy to insulin at the moment of switching oral anti-diabetics to insulin. Prick tests revealed an allergy specifically to zinc, and the patient was treated with zinc-free glulisine insulin. After 8 months of such treatment, patient's glucose is stable and he never experienced allergic reactions to insulin injections. Even insulin allergy due specifically to zinc is rare, such complication must be assessed especially in a patient suffering from multiple allergies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963448     DOI: 10.1007/s00592-010-0230-4

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  4 in total

1.  A Case of Skin, and Secondarily Generalized, Reaction to Insulin Injection.

Authors:  Olga Fidalgo; Segundo Jorge; Beatriz Veleiro; Maria L Isidro
Journal:  Clin Diabetes       Date:  2014-07

2.  Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report.

Authors:  Jennifer Badik; Jimmy Chen; Kira Letvak; Tsz-Yin So
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

Review 3.  Hypersensitivity reactions to human insulin analogs in insulin-naïve patients: a systematic review.

Authors:  Andrew S Bzowyckyj; Amanda M Stahnke
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-26       Impact factor: 3.565

4.  A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine.

Authors:  Kahori Watanabe; Yoshiki Kusunoki; Tomoyuki Katsuno; Rie Nakae; Toshihiro Matsuo; Fumihiro Ochi; Masaru Tokuda; Takafumi Akagami; Masayuki Miuchi; Jun-Ichiro Miyagawa; Mitsuyoshi Namba
Journal:  Acta Diabetol       Date:  2016-02-02       Impact factor: 4.280

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.